Participants 74 135 3
fasting islet-cell function in subjects with type 2 diabetes.
Participants 137 401 3
CONTEXT Dipeptidyl peptidase 4 (DPP-4) inhibitors are proposed to lower blood glucose in type 2 diabetes mellitus (T2DM) by prolonging the activity of the circulating incretins, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1)
Participants 929 1018 3
The study was performed in General Clinical Research Centers at two University Hospitals.
Participants 1019 1170 6
SUBJECTS Forty-one subjects with T2DM were treated with metformin or diet, having good glycemic control with glycosylated hemoglobin values of 6.2-7.5%
